Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline
Open accessThe DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In the past decades evidence has accumulated that women with reproductive and pregnancy-related disorders are at increased risk of developing cardiovascular disease (CVD) in the future. Up to now there is no standardised follow-up of these women becausee guidelines on cardiovascular risk management for this group are lacking. However, early identification of high-risk populations followed by prevention and treatment of CVD risk factors has the potential to reduce CVD incidence. Therefore, the Dutch Society of Obstetrics and Gynaecology initiated a multidisciplinary working group to develop a guideline for cardiovascular risk management after reproductive and pregnancy-related disorders. METHODS: The guideline addresses the cardiovascular risk consequences of gestational hypertension, preeclampsia, preterm delivery, small-for-gestational-age infant, recurrent miscarriage, polycystic ovary syndrome and premature ovarian insufficiency. The best available evidence on these topics was captured by systematic review. Recommendations for clinical practice were formulated based on the evidence and consensus of expert opinion. The Dutch societies of gynaecologists, cardiologists, vascular internists, radiologists and general practitioners reviewed the guideline to ensure support for implementation in clinical practice. RESULTS: For all reproductive and pregnancy-related disorders a moderate increased relative risk was found for overall CVD, except for preeclampsia (relative risk 2.15, 95% confidence interval 1.76-2.61). CONCLUSION: Based on the current available evidence, follow-up is only recommended for women with a history of preeclampsia. For all reproductive and pregnancy-related disorders optimisation of modifiable cardiovascular risk factors is recommended to reduce the risk of future CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, pregnant people with HDP or impaired glucose metabolism have an increased risk of future CMDs and premature death later in life8–10.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Fetal origins of coronary heart disease
Barker, D. J. P. (1995) · BMJ · doi:10.1136/bmj.311.6998.171 · Cited by 3,570
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
A Re-Evaluation of Random-Effects Meta-Analysis
Higgins, J. P. T., Thompson, S. G., & Spiegelhalter, D. J. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2008.00552.x · Cited by 2,569 · cited 1×
“Values of I(2)> 50% indicate significant heterogeneity.(23) Although most meta-analyses had an I(2)> 50%, all included studies showed a positive effect on the relation between CVD and preeclampsia/GH.”
BackgroundBellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Research works printed but not linked: 6
- Tucker JM, 1991, Obstet Gynecol, 77, 343
- 10.1001/jama.1986.03370010088030 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.111.034884 · DOI · Paper page
- Odegard RA, 2000, Obstet Gynecol, 96, 950
- Empson M, 2005, Cochrane Database Syst Rev, CD002859
- Roberge S, 2012, Am J Perinatol, 29, 551
Cited by
Parikh, N. I., Gonzalez, J. M., Anderson, C. A. M., Judd, S. E., Rexrode, K. M., Hlatky, M. A., Gunderson, E. P., Stuart, J. J., Vaidya, D., & On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. T. S. C. (2021) · Circulation · doi:10.1161/cir.0000000000000961 · Cited by 743
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610
Rabi, D. M., McBrien, K. A., Sapir-Pichhadze, R., Nakhla, M., Ahmed, S. B., Dumanski, S. M., Butalia, S., Leung, A. A., Harris, K. C., Cloutier, L., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.086 · Cited by 583
“Women with gestational hypertension and preeclampsia also require long-term management of their increased cardiovascular risks.(108)”
BackgroundACOG Practice Bulletin No. 212: Pregnancy and Heart Disease
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003243 · Cited by 447
Metadata
- Authors
- Heida, K. Y., Bots, M. L., de Groot, C. J., van Dunné, F. M., Hammoud, N. M., Hoek, A., Laven, J. S., Maas, A. H., Roeters van Lennep, J. E., Velthuis, B. K., & Franx, A.
- Affiliations
- University Medical Center Utrecht (NL)
- Department of Obstetrics and Gynaecology, VU University, The Netherlands
- Department of Obstetrics and Gynaecology, Medical Center Haaglanden, The Netherlands
- University of Groningen (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Department of Internal Medicine, Erasmus MC, The Netherlands
- Corresponding author
- Franx, Arie
- Venue
- European Journal of Preventive Cardiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07-20
- Volume
- 23
- Issue
- 17
- Pages
- 1863-1879
- ISSN
- 2047-4873 (ISSN-L)
- 2047-4881
- OpenAlex
- W2487394854
- Cited by
- 153
- References
- 83
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 12 · 2023: 12 · 2022: 19 · 2021: 7 · 2020: 32 · 2019: 20 · 2018: 13 · 2017: 18 · 2016: 3
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- European Journal of Preventive Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- ZonMw
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- cardiovascular risk management, pregnancy disorders, gestational hypertension, preeclampsia, preterm birth, small for gestational age, recurrent pregnancy loss, polycystic ovary syndrome, premature ovarian insufficiency, cardiovascular risk, cardiovascular risk factors, postpartum follow-up, women's cardiovascular health
- MeSH terms
- Cardiovascular Diseases, Female, Forecasting, Humans, Pregnancy, Pregnancy Complications, Cardiovascular, Risk Factors, Risk Management, Global Health, Incidence, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline. https://app.cochat.ai/papers/10.1177/2047487316659573
- The paper
- Heida, K. Y., Bots, M. L., de Groot, C. J., van Dunné, F. M., Hammoud, N. M., Hoek, A., Laven, J. S., Maas, A. H., Roeters van Lennep, J. E., Velthuis, B. K., & Franx, A. (2016). Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline. European Journal of Preventive Cardiology. https://doi.org/10.1177/2047487316659573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.